{"id":2,"date":"2021-03-03T20:36:00","date_gmt":"2021-03-04T01:36:00","guid":{"rendered":"http:\/\/reemaduggal.com\/typeonehope\/?page_id=2"},"modified":"2022-05-26T21:52:19","modified_gmt":"2022-05-27T01:52:19","slug":"home","status":"publish","type":"page","link":"https:\/\/reemaduggal.com\/typeonehope\/","title":{"rendered":"Home"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.9.1″ _module_preset=”default” background_color=”rgba(225,137,18,0.18)” background_enable_image=”off” background_blend=”multiply” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”3_5,2_5″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”3_5″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.9.10″ _module_preset=”default” text_text_color=”#17223B” text_font_size=”16px” custom_margin=”3%||5%||false|false” global_colors_info=”{}”]<\/p>\n

On February 25, 2021, my 18 year old son Hari was diagnosed with Type 1 Diabetes.<\/p>\n

We know the toll this diagnosis can take on a life and a body.<\/p>\n

My sister Seema had Type 1. She died on February 20, 2018 at the age of 50.<\/a><\/p>\n

I am determined to find researchers, clinical trials, or institutions that can cure Type 1.<\/p>\n

I am sharing this page with everyone I know with the intent of crowdsourcing information and reaching out to every possible source to make sure that Hari will get the opportunity to CRUSH Type 1 Diabetes.<\/p>\n

If you know any\u00a0 researchers, know of any trials, or find current articles that are not listed below – can I ask you to please email me and I will add it to the list.<\/p>\n

Thank you from the bottom of my heart – Reema Duggal<\/p>\n

[\/et_pb_text][et_pb_button button_url=”mailto:info@sitaran.com” button_text=”Email Me Now” _builder_version=”4.9.1″ _module_preset=”default” custom_button=”on” button_text_size=”16px” button_text_color=”#FFFFFF” button_bg_color=”#00648C” button_border_width=”0px” button_font=”Ubuntu||||||||” button_use_icon=”off” background_layout=”dark” global_colors_info=”{}” button_bg_color__hover_enabled=”on|desktop” button_bg_color__hover=”#00648C”][\/et_pb_button][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”http:\/\/reemaduggal.com\/typeonehope\/wp-content\/uploads\/2021\/03\/Hari-Drummer5.jpg” title_text=”Hari-Drummer5″ _builder_version=”4.9.1″ _module_preset=”default” border_width_all=”10px” border_color_all=”#FFFFFF” box_shadow_style=”preset1″ global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Articles” _builder_version=”4.14.1″ _module_preset=”default” background_color=”#00648C” global_colors_info=”{}”][et_pb_fullwidth_header title=”Articles” _builder_version=”4.9.1″ _module_preset=”default” title_text_align=”center” content_text_align=”center” background_color=”#00648C” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

updated 2021-11-27<\/p>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”NexImmune, Yale, and JDRF Enter into Research Partnership for Type 1 Diabetes” url=”https:\/\/www.jdrf.org\/press-releases\/neximmune-yale-and-jdrf-enter-into-600k-research-partnership-for-type-1-diabetes\/” url_new_window=”on” _builder_version=”4.14.1″ _module_preset=”default” header_text_color=”#B12725″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

JDRF
2022-05-10<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Progress Toward Cures: Thoughts at Year\u2019s End from JDRF\u2019s CEO” url=”https:\/\/www.jdrf.org\/blog\/2021\/11\/29\/progress-toward-cures-thoughts-from-jdrf-ceo-aaron-kowalski\/” url_new_window=”on” _builder_version=”4.14.1″ _module_preset=”default” header_text_color=”#B12725″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

JDRF
2021-11-29<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes” url=”https:\/\/viacyte.com\/press-releases\/crispr-therapeutics-and-viacyte-inc-to-start-clinical-trial-of-the-first-gene-edited-cell-replacement-therapy-for-treatment-of-type-1-diabetes\/” url_new_window=”on” _builder_version=”4.14.1″ _module_preset=”default” header_text_color=”#B12725″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

ViaCyte
2021-11-16<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”A Drug that Does Double Duty in Treating Diabetes” url=”https:\/\/seas.yale.edu\/news-events\/news\/drug-does-double-duty-treating-diabetes” url_new_window=”on” _builder_version=”4.14.1″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Yale
2021-11-15<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer” url=”https:\/\/viacyte.com\/press-releases\/viacyte-appoints-stem-cell-therapy-expert-dr-timothy-kieffer-as-chief-scientific-officer\/” url_new_window=”on” _builder_version=”4.14.1″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

ViaCyte
2021-09-13<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Silencing the G-protein coupled receptor 3-salt inducible kinase 2 pathway promotes human \u03b2 cell proliferation” url=”https:\/\/www.nature.com\/articles\/s42003-021-02433-2″ url_new_window=”on” _builder_version=”4.14.1″ _module_preset=”default” header_text_color=”#B12725″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Nature
2021-07-03<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Bringing Breakthroughs to Life: Type 1 Diabetes Research Symposium” url=”https:\/\/www.jdrf.ca\/advocacy\/bringing-breakthroughs-to-life-type-1-diabetes-research-symposium\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

JDRF \/ CIHR-INMD<\/span>
2021-03-31<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Discovery for turning on cell repair in tissues and organs” url=”https:\/\/www.monash.edu\/medicine\/news\/latest\/2021-articles\/discovery-for-turning-on-cell-repair-in-tissues-and-organs” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

JDRF Australia
2021-02-15<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Virtual Reception: Diabetes Research and Innovation in the Making” url=”https:\/\/www.youtube.com\/channel\/UC2ribZrcXGu7zBYOeImUR_A” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Research Canada
2021-03-02<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Event – A future without insulin: Prof Colin Dayan on immunotherapy” url=”https:\/\/www.eventbrite.co.uk\/e\/a-future-without-insulin-prof-colin-dayan-on-immunotherapy-tickets-141660886525?utm_source=twitter&utm_medium=social-media&utm_campaign=research-lives&utm_term=immunotherapy&utm_content=organic” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

YouTube Recording<\/a>
2021-03-02<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Experimental Treatment Subdues Type 1 Diabetes In Mice” url=”https:\/\/healthcare.utah.edu\/publicaffairs\/news\/2021\/02\/diabetes-holland.php” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021-02-22<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”A clinical trial will test the efficacy of the treatment IMCY-0098 in patients with recent onset Type 1 Diabetes.” url=”https:\/\/www.healtheuropa.eu\/clinical-trial-for-recent-onset-type-1-diabetes-to-test-treatment\/105780\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021-02-02<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Why Does One Scientist Seek to Find Cures for T1D? Answer: His Children” url=”https:\/\/www.jdrf.org\/blog\/2021\/01\/25\/why-does-one-scientist-seek-find-cures-type-1-diabetes-answer-children\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021-01-25<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Towards a Cure: Carleton Research Team Working on Stem Cell Therapy to Reverse Type 1 Diabetes” url=”https:\/\/research.carleton.ca\/story\/towards-a-cure-carleton-research-team-working-on-stem-cell-therapy-to-reverse-type-1-diabetes\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021-01-13<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Why Dr. Denise Faustman Isn\u2019t Deterred by Skeptics of Her Type 1 Diabetes Cure Research” url=”https:\/\/www.healthline.com\/diabetesmine\/dr-faustmans-controversial-diabetes-cure-research-continues” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021-01-12<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Endocrine Web – Type 1 Articles” url=”https:\/\/www.endocrineweb.com\/professional\/research-updates\/type-1-diabetes” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”The Future of Type I Diabetes” url=”https:\/\/www.garvan.org.au\/research\/collaborative-programs\/functional-genomics-of-type-1-diabetes-complications\/the-future-of-type-1-diabetes” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2021<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”The beginning of the end for Type 1 diabetes: A new view from immunotherapy science” url=”https:\/\/www.openaccessgovernment.org\/type-1-diabetes-immunotherapy-science\/100311\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-12-16<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Type 1 diabetes mellitus as a disease of the \u03b2-cell” url=”https:\/\/www.nature.com\/articles\/s41574-020-00443-4″ url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-12-08<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Viacyte Phase 2 Study” url=”https:\/\/viacyte.com\/press-releases\/viacyte-announces-initiation-of-phase-2-study-of-encapsulated-cell-ther-apy-for-type-1-diabetes-patients\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”This is where the horizon is\u2019: Diabetes research closer than ever to a possible cure” url=”https:\/\/www.ualberta.ca\/folio\/2020\/11\/diabetes-research-closer-than-ever-to-a-possible-cure.html” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-11-13<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Cure for diabetes? University of Alberta researchers believe they’ve found one” url=”https:\/\/edmonton.ctvnews.ca\/cure-for-diabetes-university-of-alberta-researchers-believe-they-ve-found-one-1.5192813″ url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-11-17<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Salk Institute – First immune-evading cells created to treat type 1 diabetes” url=”https:\/\/www.salk.edu\/news-release\/first-immune-evading-cells-created-to-treat-type-1-diabetes\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-08-19<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”How Immunotherapy Could Stop and Prevent Type 1 Diabetes” url=”http:\/\/How%20Immunotherapy%20Could%20Stop%20and%20Prevent%20Type%201%20Diabetes” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-03-03<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Researchers discover potential cure for type 1 diabetes using new method of creating insulin-producing cells from stem cells” url=”https:\/\/www.drwf.org.uk\/news-and-events\/news\/researchers-discover-potential-cure-type-1-diabetes-using-new-method-creating” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2020-03-04<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”A Cure for Type 1 Diabetes? A Look at the Most Promising Research” url=”https:\/\/diabetesstrong.com\/cure-for-type-1-diabetes\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2019-02-07<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Diabetes Breakthrough Increases Insulin Producing Cells” url=”https:\/\/southtexasmed.com\/diabetes-breakthrough-increases-insulin-producing-cells\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

2017-05-01<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Resetting the immune system to cure diabetes” url=”https:\/\/www.universiteitleiden.nl\/en\/research-dossiers\/immunity-infection-and-tolerance\/resetting-the-immune-system-to-cure-diabetes-and-rheumatism” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Resetting the immune system to cure diabetes<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Clinical Trials” _builder_version=”4.14.1″ _module_preset=”default” background_enable_color=”off” global_colors_info=”{}”][et_pb_fullwidth_header title=”Clinical Trials \/ Treatments” _builder_version=”4.9.1″ _module_preset=”default” title_text_align=”center” content_text_align=”center” background_color=”#00648C” global_colors_info=”{}”]<\/p>\n

updated 2021-03-04<\/p>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”BC Diabetes | Canada” url=”https:\/\/www.bcdiabetes.ca\/wp-content\/uploads\/bcdpdfs\/Ustekinumab-in-newly-diagnosed-Type-1-RCT-UST1D2.pdf” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Ustekinumab RCT- UST1D2<\/p>\n

2021<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”City of Hope | USA” url=”https:\/\/www.cityofhope.org\/breakthroughs\/-phase-1-type-1-diabetes-investigational-vaccine-trial-opens” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

City of Hope opens investigational vaccine trial for type 1 diabetes<\/p>\n

2021<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Islet.ca | Canada” url=”http:\/\/www.islet.ca” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Clinical Islet Transplant Program<\/p>\n

2021<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”TrialNet | Global” url=”https:\/\/www.trialnet.org\/our-research\/newly-diagnosed-t1d\/TOPPLE” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Our goal: a future without T1D!<\/p>\n

Topple Study – Now Enrolling<\/p>\n

Ongoing<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Drifcan | Canada” url=”https:\/\/www.drifcan.com\/research\/#researchvideos” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Stem Cell-Derived Islet Replacement Therapy<\/p>\n

2021<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Innodia | Europe” url=”https:\/\/www.innodia.eu\/patients\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]Private\/Public Partnership Against Type 1<\/p>\n

Ongoing[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Medacess | India” url=”https:\/\/www.medacess.com\/treatments\/stem-cell-treatment-diabetes-type1.html” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Stem Cell Therapy<\/p>\n

ongoing<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Giostar | India” url=”https:\/\/www.giostar.com\/Therapy\/diabetes-type-1\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Stem Cell Therapy<\/p>\n

ongoing<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Researchers” _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_fullwidth_header title=”Researchers” _builder_version=”4.14.1″ _module_preset=”default” title_text_align=”center” content_text_align=”center” background_color=”#00648C” global_colors_info=”{}”]<\/p>\n

updated 2021-03-04<\/p>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”James Shapiro” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

\u00a0<\/span>isletprogram@islet.ca<\/a>
University of Alberta, Canada<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Jan Dutz\/Tom Elliott” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

bcdiabetes.ca<\/a>
British Columbia Canada<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Denise Faustman” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

DiabetesTrial@partners.org
Massachusets General Hospital, USA<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Jenny Bruin” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

Jenny.Bruin@carleton.ca
Carleton University, Canada<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Bart Roep” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

b.o.roep@lumc.nl
Leiden University, Netherlands<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Colin Dayan” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

dayancm@cardiff.ac.uk
Cardiff University, England<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Groups” _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_fullwidth_header title=”Groups \/ Organizations” _builder_version=”4.9.3″ _module_preset=”default” title_text_align=”center” content_text_align=”center” background_color=”#00648C” global_colors_info=”{}”]<\/p>\n

updated 2021-04-05<\/p>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”JDRF” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

www.jdrf.ca<\/a>\u00a0
www.jdrf.org<\/a>\u00a0
<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Diabetes Canada” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

www.diabetes.ca<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Diabetes Action Canada” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

www.diabetesaction.ca<\/a>\u00a0<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Connected In Motion” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

www.connectedinmotion.ca<\/a>\u00a0<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Diabetes Wise” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

diabeteswise.org<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Connect1D” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ global_colors_info=”{}”]<\/p>\n

connect1d.ca<\/a><\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Companies” _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_fullwidth_header title=”Companies \/ New Products” _builder_version=”4.9.1″ _module_preset=”default” title_text_align=”center” content_text_align=”center” background_color=”#00648C” global_colors_info=”{}”]<\/p>\n

updated 2021-03-20<\/p>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Viacyte” url=”https:\/\/viacyte.com\/press-releases\/viacyte-reports-compelling-preliminary-clinical-data-from-islet-cell-replacement-therapy-for-patients-with-type-1-diabetes\/” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]ViaCyte Reports Compelling Preliminary Clinical Data from Islet Cell Replacement Therapy for Patients with Type 1 Diabetes[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Sernova” url=”https:\/\/www.sernova.com\/” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]<\/p>\n

Sernova is a regenerative medicine therapeutics company<\/p>\n

London, Ontario<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Vertex” url=”https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-announces-fda-fast-track-designation-and-initiation-phase” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]Novel Investigational Cell Therapy for the Treatment of Type 1 Diabetes<\/p>\n

Boston, Massachusetts[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Eversense” url=”https:\/\/www.contournext.com\/eversense” url_new_window=”on” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]<\/p>\n

90-Day Eversense CGM<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ use_custom_gutter=”on” _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Connected In Motion” url=”https:\/\/www.connectedinmotion.ca\/” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]<\/p>\n

Support & engagement in diabetes self-management through peer-based experiential diabetes education, sport, and outdoor adventure.<\/span><\/p>\n

Ontario<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Nightscout” url=”http:\/\/www.nightscout.info\/” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]Nightscout (CGM in the Cloud) is an open source, DIY project that allows real time access to a CGM data via personal website, smartwatch viewers, or apps and widgets available for smartphones.<\/p>\n

Online[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Beta Bionics” url=”https:\/\/www.betabionics.com\/” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]A fully automated bionic pancreas<\/p>\n

Online[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.9.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”The BioSensor Platform” url=”https:\/\/gbs.inc\/the-biosensor-platform\/” _builder_version=”4.13.0″ _module_preset=”default” header_text_color=”#B12725″ link_option_url_new_window=”on” global_colors_info=”{}”]<\/p>\n

World-first Organic Thin Film Transistor (OTFT) technology<\/p>\n

Online<\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

On February 25, 2021, my 18 year old son Hari was diagnosed with Type 1 Diabetes. We know the toll this diagnosis can take on a life and a body. My sister Seema had Type 1. She died on February 20, 2018 at the age of 50. I am determined to find researchers, clinical trials, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"\n

This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this:<\/p>\n\n\n\n

Hi there! I'm a bike messenger by day, aspiring actor by night, and this is my website. I live in Los Angeles, have a great dog named Jack, and I like pi\u00f1a coladas. (And gettin' caught in the rain.)<\/p><\/blockquote>\n\n\n\n

...or something like this:<\/p>\n\n\n\n

The XYZ Doohickey Company was founded in 1971, and has been providing quality doohickeys to the public ever since. Located in Gotham City, XYZ employs over 2,000 people and does all kinds of awesome things for the Gotham community.<\/p><\/blockquote>\n\n\n\n

As a new WordPress user, you should go to your dashboard<\/a> to delete this page and create new pages for your content. Have fun!<\/p>\n","_et_gb_content_width":"","footnotes":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":52,"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":157,"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/pages\/2\/revisions\/157"}],"wp:attachment":[{"href":"https:\/\/reemaduggal.com\/typeonehope\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}